| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,607 | 2,422 | 2,868 | 3,061 | 3,199 | 3,079 | 3,570 | 3,697 | 3,567 | 3,443 | 4,031 | 4,338 | |
Growth YoY Revenue Growth YoY% | 24.7 | 18.0 | 11.2 | 13.1 | 22.7 | 27.1 | 24.5 | 20.8 | 11.5 | 11.8 | 12.9 | 17.3 |
| 2,000 | 1,836 | 2,196 | 2,214 | 2,383 | 2,396 | 2,724 | 2,776 | 2,648 | 2,513 | 2,974 | 3,167 | |
| 607 | 586 | 672 | 847 | 816 | 683 | 847 | 921 | 919 | 930 | 1,056 | 1,171 | |
OPM OPM% | 23.3 | 24.2 | 23.4 | 27.7 | 25.5 | 22.2 | 23.7 | 24.9 | 25.8 | 27.0 | 26.2 | 27.0 |
| 75 | 95 | 103 | 112 | 80 | 254 | 83 | 94 | -31 | 94 | 49 | 99 | |
Interest Expense Interest ExpenseCr | 9 | 9 | 11 | 7 | 221 | 191 | 171 | 170 | 157 | 142 | 110 | 105 |
Depreciation DepreciationCr | 110 | 100 | 103 | 100 | 187 | 231 | 219 | 222 | 223 | 223 | 226 | 236 |
PBT PBTCr | 562 | 572 | 661 | 851 | 488 | 515 | 540 | 624 | 509 | 659 | 769 | 929 |
| 103 | 95 | 123 | 190 | 110 | 86 | 96 | 104 | 95 | 100 | 195 | 213 | |
| 460 | 477 | 543 | 659 | 385 | 425 | 445 | 520 | 414 | 559 | 574 | 716 | |
Growth YoY PAT Growth YoY% | 55.5 | 62.3 | 9.9 | 28.9 | -16.4 | -10.9 | -18.1 | -21.1 | 7.6 | 31.7 | 29.1 | 37.7 |
NPM NPM% | 17.6 | 19.7 | 18.9 | 21.5 | 12.0 | 13.8 | 12.4 | 14.1 | 11.6 | 16.3 | 14.2 | 16.5 |
| 11.3 | 11.8 | 13.4 | 16.3 | 9.5 | 10.2 | 10.6 | 12.4 | 9.9 | 13.4 | 13.8 | 17.2 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,607 | 2,422 | 2,868 | 3,061 | 3,199 | 3,079 | 3,570 | 3,697 | 3,567 | 3,443 | 4,031 | 4,338 | |
Growth YoY Revenue Growth YoY% | 24.7 | 18.0 | 11.2 | 13.1 | 22.7 | 27.1 | 24.5 | 20.8 | 11.5 | 11.8 | 12.9 | 17.3 |
| 2,000 | 1,836 | 2,196 | 2,214 | 2,383 | 2,396 | 2,724 | 2,776 | 2,648 | 2,513 | 2,974 | 3,167 | |
| 607 | 586 | 672 | 847 | 816 | 683 | 847 | 921 | 919 | 930 | 1,056 | 1,171 | |
OPM OPM% | 23.3 | 24.2 | 23.4 | 27.7 | 25.5 | 22.2 | 23.7 | 24.9 | 25.8 | 27.0 | 26.2 | 27.0 |
| 75 | 95 | 103 | 112 | 80 | 254 | 83 | 94 | -31 | 94 | 49 | 99 | |
Interest Expense Interest ExpenseCr | 9 | 9 | 11 | 7 | 221 | 191 | 171 | 170 | 157 | 142 | 110 | 105 |
Depreciation DepreciationCr | 110 | 100 | 103 | 100 | 187 | 231 | 219 | 222 | 223 | 223 | 226 | 236 |
PBT PBTCr | 562 | 572 | 661 | 851 | 488 | 515 | 540 | 624 | 509 | 659 | 769 | 929 |
| 103 | 95 | 123 | 190 | 110 | 86 | 96 | 104 | 95 | 100 | 195 | 213 | |
| 460 | 477 | 543 | 659 | 385 | 425 | 445 | 520 | 414 | 559 | 574 | 716 | |
Growth YoY PAT Growth YoY% | 55.5 | 62.3 | 9.9 | 28.9 | -16.4 | -10.9 | -18.1 | -21.1 | 7.6 | 31.7 | 29.1 | 37.7 |
NPM NPM% | 17.6 | 19.7 | 18.9 | 21.5 | 12.0 | 13.8 | 12.4 | 14.1 | 11.6 | 16.3 | 14.2 | 16.5 |
| 11.3 | 11.8 | 13.4 | 16.3 | 9.5 | 10.2 | 10.6 | 12.4 | 9.9 | 13.4 | 13.8 | 17.2 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 5,865 | 6,214 | 7,782 | 8,749 | 10,260 | 12,207 | 14,278 | 15,379 |
Growth Revenue Growth% | 6.0 | 25.2 | 12.4 | 17.3 | 19.0 | 17.0 | 13.5 | |
| 4,428 | 4,566 | 5,792 | 6,849 | 7,747 | 9,190 | 10,660 | 11,302 | |
| 1,437 | 1,648 | 1,989 | 1,901 | 2,514 | 3,018 | 3,617 | 4,077 | |
OPM OPM% | 24.5 | 26.5 | 25.6 | 21.7 | 24.5 | 24.7 | 25.3 | 26.5 |
| 122 | 183 | 210 | 141 | 295 | 549 | 241 | 211 | |
Interest Expense Interest ExpenseCr | 22 | 20 | 59 | 44 | 33 | 429 | 639 | 514 |
Depreciation DepreciationCr | 99 | 119 | 167 | 326 | 378 | 621 | 886 | 907 |
PBT PBTCr | 1,438 | 1,692 | 1,975 | 1,671 | 2,398 | 2,516 | 2,333 | 2,867 |
| 382 | 399 | 522 | 362 | 457 | 510 | 395 | 603 | |
PAT PATCr | 1,056 | 1,293 | 1,453 | 1,310 | 1,941 | 2,007 | 1,938 | 2,264 |
Growth PAT Growth% | 22.4 | 12.4 | -9.9 | 48.2 | 3.4 | -3.4 | 27.6 | |
NPM NPM% | 18.0 | 20.8 | 18.7 | 15.0 | 18.9 | 16.4 | 13.6 | 14.7 |
| 25.7 | 31.6 | 35.8 | 32.0 | 47.8 | 49.3 | 46.4 | 54.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 5,865 | 6,214 | 7,782 | 8,749 | 10,260 | 12,207 | 14,278 | 15,379 |
Growth Revenue Growth% | 6.0 | 25.2 | 12.4 | 17.3 | 19.0 | 17.0 | 13.5 | |
| 4,428 | 4,566 | 5,792 | 6,849 | 7,747 | 9,190 | 10,660 | 11,302 | |
| 1,437 | 1,648 | 1,989 | 1,901 | 2,514 | 3,018 | 3,617 | 4,077 | |
OPM OPM% | 24.5 | 26.5 | 25.6 | 21.7 | 24.5 | 24.7 | 25.3 | 26.5 |
| 122 | 183 | 210 | 141 | 295 | 549 | 241 | 211 | |
Interest Expense Interest ExpenseCr | 22 | 20 | 59 | 44 | 33 | 429 | 639 | 514 |
Depreciation DepreciationCr | 99 | 119 | 167 | 326 | 378 | 621 | 886 | 907 |
PBT PBTCr | 1,438 | 1,692 | 1,975 | 1,671 | 2,398 | 2,516 | 2,333 | 2,867 |
| 382 | 399 | 522 | 362 | 457 | 510 | 395 | 603 | |
PAT PATCr | 1,056 | 1,293 | 1,453 | 1,310 | 1,941 | 2,007 | 1,938 | 2,264 |
Growth PAT Growth% | 22.4 | 12.4 | -9.9 | 48.2 | 3.4 | -3.4 | 27.6 | |
NPM NPM% | 18.0 | 20.8 | 18.7 | 15.0 | 18.9 | 16.4 | 13.6 | 14.7 |
| 25.7 | 31.6 | 35.8 | 32.0 | 47.8 | 49.3 | 46.4 | 54.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 40 | 40 | 40 | 40 | 40 | 41 | 41 | 41 |
Reserves ReservesCr | 3,445 | 4,682 | 6,115 | 7,395 | 9,323 | 14,291 | 16,259 | 17,541 |
| 1,259 | 1,353 | 2,623 | 1,863 | 2,120 | 5,664 | 6,507 | 5,885 | |
| 143 | 156 | 208 | 229 | 268 | 7,528 | 5,011 | 5,214 | |
| 5,073 | 6,373 | 9,148 | 9,715 | 11,963 | 27,760 | 28,080 | 28,954 | |
| 2,822 | 3,907 | 4,407 | 4,328 | 6,568 | 6,988 | 6,954 | 7,956 | |
| 2,251 | 2,466 | 4,741 | 5,388 | 5,395 | 20,771 | 21,125 | 20,998 | |
| 5,073 | 6,373 | 9,148 | 9,715 | 11,963 | 27,760 | 28,080 | 28,954 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 40 | 40 | 40 | 40 | 40 | 41 | 41 | 41 |
Reserves ReservesCr | 3,445 | 4,682 | 6,115 | 7,395 | 9,323 | 14,291 | 16,259 | 17,541 |
| 1,259 | 1,353 | 2,623 | 1,863 | 2,120 | 5,664 | 6,507 | 5,885 | |
| 143 | 156 | 208 | 229 | 268 | 7,528 | 5,011 | 5,214 | |
| 5,073 | 6,373 | 9,148 | 9,715 | 11,963 | 27,760 | 28,080 | 28,954 | |
| 2,822 | 3,907 | 4,407 | 4,328 | 6,568 | 6,988 | 6,954 | 7,956 | |
| 2,251 | 2,466 | 4,741 | 5,388 | 5,395 | 20,771 | 21,125 | 20,998 | |
| 5,073 | 6,373 | 9,148 | 9,715 | 11,963 | 27,760 | 28,080 | 28,954 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 1,070 | 1,137 | 920 | 1,813 | 2,152 | 2,413 | 3,121 | |
| -439 | -1,222 | -1,369 | -1,054 | -2,082 | -12,683 | -196 | |
| -531 | -8 | 605 | -740 | 5 | 10,233 | -2,953 | |
Net Cash Flow Net Cash FlowCr | 100 | -93 | 155 | 19 | 76 | -37 | -28 |
Free Cash Flow Free Cash FlowCr | 878 | 833 | 458 | 1,030 | 1,845 | 1,965 | 2,498 |
CFO To PAT CFO To PAT% | 101.3 | 88.0 | 63.3 | 138.4 | 110.9 | 120.3 | 161.1 |
CFO To EBITDA CFO To EBITDA% | 74.5 | 69.0 | 46.2 | 95.4 | 85.6 | 80.0 | 86.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 1,070 | 1,137 | 920 | 1,813 | 2,152 | 2,413 | 3,121 | |
| -439 | -1,222 | -1,369 | -1,054 | -2,082 | -12,683 | -196 | |
| -531 | -8 | 605 | -740 | 5 | 10,233 | -2,953 | |
Net Cash Flow Net Cash FlowCr | 100 | -93 | 155 | 19 | 76 | -37 | -28 |
Free Cash Flow Free Cash FlowCr | 878 | 833 | 458 | 1,030 | 1,845 | 1,965 | 2,498 |
CFO To PAT CFO To PAT% | 101.3 | 88.0 | 63.3 | 138.4 | 110.9 | 120.3 | 161.1 |
CFO To EBITDA CFO To EBITDA% | 74.5 | 69.0 | 46.2 | 95.4 | 85.6 | 80.0 | 86.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 92,029 | 99,974 | 82,807 | 1,10,077 | ||||
Price To Earnings Price To Earnings | 48.1 | 50.2 | 1.1 | 49.0 | ||||
Price To Sales Price To Sales | 9.0 | 8.2 | 5.8 | 7.2 | ||||
Price To Book Price To Book | 9.8 | 7.0 | 0.1 | 6.3 | ||||
EV To EBITDA EV To EBITDA | 36.4 | 35.8 | 24.5 | 28.1 | ||||
GPM GPM% | 65.1 | 68.5 | 66.1 | 63.9 | 66.0 | 68.1 | 68.2 | 68.2 |
OPM OPM% | 24.5 | 26.5 | 25.6 | 21.7 | 24.5 | 24.7 | 25.3 | 26.5 |
NPM NPM% | 18.0 | 20.8 | 18.7 | 15.0 | 18.9 | 16.4 | 13.6 | 14.7 |
ROCE ROCE% | 40.4 | 34.5 | 28.9 | 22.6 | 25.4 | 12.9 | 13.1 | 14.8 |
ROE ROE% | 30.3 | 27.4 | 23.6 | 17.6 | 20.7 | 14.0 | 11.9 | 12.9 |
ROA ROA% | 20.8 | 20.3 | 15.9 | 13.5 | 16.2 | 7.2 | 6.9 | 7.8 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 92,029 | 99,974 | 82,807 | 1,10,077 | ||||
Price To Earnings Price To Earnings | 48.1 | 50.2 | 1.1 | 49.0 | ||||
Price To Sales Price To Sales | 9.0 | 8.2 | 5.8 | 7.2 | ||||
Price To Book Price To Book | 9.8 | 7.0 | 0.1 | 6.3 | ||||
EV To EBITDA EV To EBITDA | 36.4 | 35.8 | 24.5 | 28.1 | ||||
GPM GPM% | 65.1 | 68.5 | 66.1 | 63.9 | 66.0 | 68.1 | 68.2 | 68.2 |
OPM OPM% | 24.5 | 26.5 | 25.6 | 21.7 | 24.5 | 24.7 | 25.3 | 26.5 |
NPM NPM% | 18.0 | 20.8 | 18.7 | 15.0 | 18.9 | 16.4 | 13.6 | 14.7 |
ROCE ROCE% | 40.4 | 34.5 | 28.9 | 22.6 | 25.4 | 12.9 | 13.1 | 14.8 |
ROE ROE% | 30.3 | 27.4 | 23.6 | 17.6 | 20.7 | 14.0 | 11.9 | 12.9 |
ROA ROA% | 20.8 | 20.3 | 15.9 | 13.5 | 16.2 | 7.2 | 6.9 | 7.8 |
| Market CapitalizationMkt CapCr | 1,19,700 | 1,16,119 | 1,14,316 | 1,10,077 | 1,03,510 | 92,099 | 74,733 |
| Close PriceClose₹ | 1,200.00 | 1,390.20 | 1,415.00 | 2,665.00 | 1,799.00 | 2,014.00 | 2,648.00 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 28.67 | 41.36 | 39.45 | 49.05 | 26.09 | 17.24 | 51.49 |
| Price To SalesPS | 3.94 | 3.51 | 4.06 | 7.16 | 2.80 | 3.00 | 4.69 |
| RevenueRevenueCr | 30,378 | 33,097 | 28,139 | 15,379 | 36,913 | 30,746 | 15,937 |
| Revenue Growth TTMRev Gr TTM% | 24.0% | -3.5% | -0.7% | 13.5% | 13.5% | 24.2% | -0.1% |
| PAT Growth TTMPAT Gr TTM% | -14.6% | -51.9% | -47.4% | 27.6% | 16.5% | 20.1% | 43.7% |
| Market CapitalizationMkt CapCr | 1,19,700 | 1,16,119 | 1,14,316 | 1,10,077 | 1,03,510 | 92,099 | 74,733 |
| Close PriceClose₹ | 1,200.00 | 1,390.20 | 1,415.00 | 2,665.00 | 1,799.00 | 2,014.00 | 2,648.00 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 28.67 | 41.36 | 39.45 | 49.05 | 26.09 | 17.24 | 51.49 |
| Price To SalesPS | 3.94 | 3.51 | 4.06 | 7.16 | 2.80 | 3.00 | 4.69 |
| RevenueRevenueCr | 30,378 | 33,097 | 28,139 | 15,379 | 36,913 | 30,746 | 15,937 |
| Revenue Growth TTMRev Gr TTM% | 24.0% | -3.5% | -0.7% | 13.5% | 13.5% | 24.2% | -0.1% |
| PAT Growth TTMPAT Gr TTM% | -14.6% | -51.9% | -47.4% | 27.6% | 16.5% | 20.1% | 43.7% |